DYN
Dyne Therapeutics, Inc. · Healthcare
Director Jason P Rhodes sold $4.2M of Dyne Therapeutics, Inc.
Sold$4,178,516
$18.38Price
227,337Shares
−16%Stake
What DYN did after the filing
- The stock from Fri, May 1 open, $17.46
- +7.3%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Jun 15 close.
Traded Tue, Apr 28. Filed Thu, Apr 30, 5:22 PM ET, after the close. Returns use the May 1 open and the Jun 15 close. Not investment advice.